TERCICA

tercica-logo

Tercica Inc., a biotechnology company, engages in the development and commercialization of therapeutics for the treatment of endocrine and metabolic diseases. Its products include Increlex, an rDNA origin injection for the long-term treatment of children with short stature due to severe primary IGFD; and Somatuline Depot, a lanreotide injection for the treatment of adults with acromegaly. Tercica Inc. has strategic partnerships with Genentech and Ipsen SA. The company was founded in 2002 and is based in Brisbane, California. As of October 16, 2008, Tercica Inc. operates as a subsidiary of Ipsen S.A.

#SimilarOrganizations #People #Financial #Website #More

TERCICA

Social Links:

Industry:
Biotechnology Children Pharmaceutical

Founded:
2000-01-01

Address:
Brisbane, California, United States

Country:
United States

Website Url:
http://www.ipsenus.com

Total Employee:
501+

Status:
Active

Contact:
9082756301

Email Addresses:
[email protected]

Total Funding:
148.5 M USD

Technology used in webpage:
Amazon Amazon Route 53 Amazon CloudFront Vimeo Vimeo CDN


Similar Organizations

alnara-pharmaceuticals-logo

Alnara Pharmaceuticals

Alnara Pharmaceuticals develops and commercializes orally-delivered protein therapeutics for the treatment of metabolic diseases.

epivax-logo

EpiVax

EpiVax is an immunology company developing comprehensive analytical capabilities in the field of computational immunology.

myr-gmbh-logo

MYR GmbH

MYR is a biotechnology company developing and commercilizing therapeutics for the treatment of chronic hepatitis B and D infections.


Current Advisors List

wayne-hockmeyer_image

Wayne Hockmeyer Member of Board of Directors @ Tercica
Board_member

alex-barkas_image

Alex Barkas Board of Directors @ Tercica
Board_member

peter-svennilson_image

Peter Svennilson Board Member @ Tercica
Board_member

mark-leschly_image

Mark Leschly Member of the Board of Directors @ Tercica
Board_member

Stock Details


Company's stock symbol is NASDAQ:TRCA

Investors List

genenfund_image

GenenFUND

GenenFUND investment in Post-IPO Equity - Tercica

kingsbridge-capital_image

Kingsbridge Capital

Kingsbridge Capital investment in Post-IPO Equity - Tercica

care-capital_image

Care Capital

Care Capital investment in Series B - Tercica

mpm-capital_image

MPM Capital

MPM Capital investment in Series B - Tercica

prospect-venture-partners_image

Prospect Venture Partners

Prospect Venture Partners investment in Series B - Tercica

rho-ventures_image

Rho Ventures

Rho Ventures investment in Series B - Tercica

medimmune-ventures_image

MedImmune Ventures

MedImmune Ventures investment in Series B - Tercica

genentech_image

Genentech

Genentech investment in Series A - Tercica

Official Site Inspections

http://www.ipsenus.com

  • Host name: server-108-138-128-71.jfk50.r.cloudfront.net
  • IP address: 108.138.128.71
  • Location: Seattle United States
  • Latitude: 47.54
  • Longitude: -122.3032
  • Metro Code: 819
  • Timezone: America/Los_Angeles
  • Postal: 98108

Loading ...

More informations about "Tercica" on Search Engine